MBHB Partner Kevin Noonan Quoted in Bloomberg Law Article Entitled, “Risk-Averse Pharma Companies Get Creative to Invest in New Drugs”
February 10, 2021
McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in a February 10, 2021 Bloomberg Law article entitled, “Risk-Averse Pharma Companies Get Creative to Invest in New Drugs.” View the article
